The first 1 monthly non-hormonal contraceptive product is expected to interview
On October 10, Daré Bioscience announced that the FDA granted an Investigational Device Exemption (IDE) application allowing it to conduct a pivotal Phase III clinical
On October 10, Daré Bioscience announced that the FDA granted an Investigational Device Exemption (IDE) application allowing it to conduct a pivotal Phase III clinical
On October 10, according to foreign media reports, the AstraZeneca/Oxford University Intranasal COVID-19 vaccine did not work well in early studies. The results showed that
Carcinomas and sarcomas are collectively referred to as malignant tumors, also commonly known as cancers. 1. Carcinomas and sarcomas differ in the tissues from which
On October 10, Merck announced that its potential “first-in-class” therapy sotatercept met the primary clinical endpoint in a Phase 3 clinical trial for the treatment
The successful development of all anticancer drugs requires a crucial step prior to human trials, the preclinical assessment of the efficacy of the treatment using
Breast cancer is one of the most common malignant tumors in women. In many countries, breast cancer ranks first in the mortality rate of female
On October 6, Allogene announced the initiation of the Phase II ALPHA2 trial of the investigational allogeneic CAR T therapy ALLO-501A for the treatment of
Oramed Subsidiary Oravax Reports Positive Preliminary Phase 1 Data for its Oral Covid-19 Vaccine -Primary and secondary endpoints of safety and immunogenicity met -Oral vaccine
On October 4, the U.S. Department of Health and Human Services (HHS) announced that it was purchasing roprostim from Amgen to respond to radiological and
On October 6, Provention announced an agreement with Sanofi to jointly advance the commercialization of teplizumab. Previously, the FDA has accepted a Biologics License Application
The University of Queensland in Australia has announced that a new study has revealed how COVID-19 affects the heart and how it differs from that
In a new study, an international team has identified 89 genetic loci associated with stroke risk and six genes that are potential drug targets for